Thai (ภาษาไทย)English (United Kingdom)

Echo News: Role model of Echo Lab in Regions

Adult Noninvasive Cardiovascular Lab welcomed Mr. Kumaran Govindasamy, senior cardiovascular technologist from Prince Court Medical Center, Kuala Lumpur, Malaysia. His visit on 5-6 October, 2017 focused on the IT system integration with the workflow in KCMH Noninvasive CV Lab and QLab™ software training on site.

From left to right: Ms. Rajit Suwunnakart , Ms. Wanvisa Tananyutthawong, Dr. Smonporn Boonyaratavej Songmuang, Mr. Kumaran Govindasamy and Mr. Azizi Zainol

Home
Left Atrium Appendage Occluder Device PDF Print E-mail
Monday, 11 February 2013 06:04

Atrial fibrillation is an irregular heart beat which can cause blood clot in the heart and embolic stroke. Prevention of stroke can be managed by anticoagulation (Blood thinner). However, some patients are contraindicated to the blood thinner. Left atrium appendage (LAA) occluder device is a new technology developed to occupy the space in the heart (LAA) where the blood clot forms as an alternative treatment for blood thinner. The device placement can be performed by catheter technique via the access of the artery beneath the groin area without a need for open heart surgery. The length of hospital stay is 1-2 days.

Cardiac Center at King Chulalongkorn Memorial Hospital is the first in Thailand successfully performed LAA occlude device placement in two patients with atrial fibrillation. More details are in Thai.

 

 

KCMH Cardiac Center Staff Login

Donation

We provide the best service to our patients from the funding we receive. However, the high demands for medical equipments and supports mean that donations make a very important difference.

For more information please click here

Statistics

Content View Hits : 3637276

Health Promotion

KCMH Cardiac Center E- letters